Artificial Heartlung Machine Market Report
First published: 11 October 2024 | Last updated: 25 May 2026 | Report Code: artificial-heartlung-machine
Artificial Heartlung Machine Market — USD 5.7 billion in 2023, Growing to USD 11.65B by 2033 at 7.2% CAGR
This report provides an in-depth analysis of the Artificial Heartlung Machine market, highlighting insights on market size, growth forecasts, and industry trends for the period 2023 to 2033.
Key Takeaways
- Global market expands from $5.70 Billion in 2023 to $11.65 Billion in 2033 at a 7.2% CAGR.
- North America is largest regional market, while no single fastest-growing region is stated because regional CAGR differences remain within 0.15 percentage points.
- Europe grows from $1.62 Billion in 2023 to $3.31 Billion in 2033; Asia Pacific expands from $1.09 Billion to $2.23 Billion in the same period.
- Top companies include Medtronic, Abbott Laboratories, Terumo Corporation, Getinge AB, and Sorin Group, reflecting active industry competition and innovation.
Artificial Heartlung Machine Market Report — Executive Summary
North America remains largest market by forecast-period value, while no single fastest-growing region is stated because top regional growth rates are separated by less than 0.15 percentage points. The report examines market expansion driven by technological advances, rising incidence of cardiopulmonary conditions, and broader healthcare access. Key trends include device miniaturization, improved monitoring integration and enhanced consumables supporting surgical and critical care use. Regional patterns show North America as the largest market, with significant adoption across Europe and Asia Pacific. The analysis is structured across product types, end users, applications and regions, and profiles leading suppliers such as Medtronic and Abbott Laboratories. Methodology combines expert interviews with company publications and data validation to present a clear view of demand, supply-side innovation, and adoption barriers for stakeholders.
Key Growth Drivers
- Increasing prevalence of cardiovascular and respiratory conditions raising demand for perioperative and critical care support.
- Continued product innovation in device functionality, monitoring and portability improving clinical utility.
- Expansion of healthcare infrastructure and greater surgical capacity in several regions increasing equipment purchases.
- Focus on patient safety and outcomes prompting hospitals and research institutes to upgrade to newer heartlung systems.
- Rising procedural volumes for cardiac and transplant surgeries supporting aftermarket consumables and services.
| Metric | Value |
|---|---|
| Study Period | 2023 - 2033 |
| 2023 Market Size | $5.70 Billion |
| CAGR (2023-2033) | 7.2% |
| 2033 Market Size | $11.65 Billion |
| Top Companies | Medtronic , Abbott Laboratories, Terumo Corporation, Getinge AB, Sorin Group |
| Published Date | 11 October 2024 |
| Last Modified Date | 25 May 2026 |
Artificial Heartlung Machine Market Overview
Customize Artificial Heartlung Machine Market Report market research report
- ✔ Get in-depth analysis of Artificial Heartlung Machine market size, growth, and forecasts.
- ✔ Understand Artificial Heartlung Machine's regional dynamics and industry-specific trends.
- ✔ Identify potential applications, end-user demand, and growth segments in Artificial Heartlung Machine
What is the Market Size & CAGR of Artificial Heartlung Machine Market Report market in 2023?
Artificial Heartlung Machine Industry Analysis
Artificial Heartlung Machine Market Segmentation and Scope
Tell us your focus area and get a customized research report.
Artificial Heartlung Machine Market Report Market Analysis Report by Region
Europe Artificial Heartlung Machine Market Report:
Europe grows from $1.62 Billion in 2023 to $3.31 Billion in 2033. Expansion is influenced by established healthcare systems, emphasis on patient safety and outcomes, and continued uptake of newer device generations in cardiac and critical care settings.Asia Pacific Artificial Heartlung Machine Market Report:
Asia Pacific grows from $1.09 Billion in 2023 to $2.23 Billion in 2033. Growth in the region is supported by enhancements in healthcare access, increasing surgical capacity, and greater investment in life-sciences technologies.North America Artificial Heartlung Machine Market Report:
North America is largest regional market, rising from $1.97 Billion in 2023 to $4.03 Billion in 2033. The region’s scale reflects broad clinical adoption, investment in surgical infrastructure, and demand from hospitals and research institutes for advanced heartlung systems.South America Artificial Heartlung Machine Market Report:
Latin America grows from $0.32 Billion in 2023 to $0.65 Billion in 2033. Regional gains reflect gradual expansion of healthcare infrastructure and selective adoption of advanced perioperative equipment in major clinical centers.Middle East & Africa Artificial Heartlung Machine Market Report:
Middle East and Africa grows from $0.7 Billion in 2023 to $1.43 Billion in 2033. Progress is driven by investments in medical facilities, growing clinical capabilities and targeted procurement of devices for cardiac and respiratory care.Tell us your focus area and get a customized research report.
Research Methodology
Artificial Heartlung Machine Market Analysis By Product
In 2023, the Invasive Devices segment dominates the market with a size of $3.45 billion and retains a share of 60.5%. This dominance is attributed to the necessity of invasive procedures in critical care scenarios. The Non-Invasive Devices segment, valued at $1.57 billion (27.62% share), and Consumables at $0.68 billion (11.88% share) are also significant contributors, representing their growing importance in patient care and operational efficiency.
Artificial Heartlung Machine Market Analysis By Application
The market by application includes key segments such as Cardiac Surgery, which dominates with a size of $2.45 billion (42.97% share) in 2023, followed by Respiratory Failure and Heart Transplantation, valued at $1.27 billion (22.25%) and $0.75 billion (13.1%), respectively. The growth in these applications is driven by advancements in surgical techniques and a growing number of patients requiring heart and lung interventions.
Artificial Heartlung Machine Market Analysis By End User
Hospitals represent the largest segment by end-user, valued at $3.29 billion (57.76% share) in 2023, emphasizing their critical role in healthcare. Ambulatory Surgery Centers and Urgent Care Centers also contribute significantly, valued at $1.40 billion (24.61%) and $0.55 billion (9.58%), respectively, driven by the increasing prevalence of outpatient surgeries and urgent medical needs.
Artificial Heartlung Machine Market Analysis By Region
Regional analysis underscores North America's leadership in market size and growth potential. Europe follows closely with advancements in healthcare infrastructure and patient care. The Asia-Pacific region exhibits rapid growth due to rising healthcare access, while South America and the Middle East & Africa are poised for incremental expansion fueled by healthcare improvements and increased investments.
Artificial Heartlung Machine Market Trends and Future Forecast
Tell us your focus area and get a customized research report.
Global Market Leaders and Top Companies in Artificial Heartlung Machine Industry
Medtronic :
A leading global supplier of healthcare solutions, known for innovations in cardiac devices including heartlung machines and related technology.Abbott Laboratories:
A prominent healthcare manufacturer with a focus on cardiovascular devices, contributing significantly to the development of advanced heartlung support systems.Terumo Corporation:
A diversified medical device manufacturer that focuses on innovations in heart-lung machines and cardiopulmonary support technologies.Getinge AB:
A global leader in providing advanced solutions for healthcare, particularly in critical care and surgical applications involving artificial heart and lung machines.Sorin Group:
Specialized in cardiac surgery products, including blood management devices and heartlung machines that enhance surgical procedures and patient outcomes.We're grateful to work with incredible clients.
FAQs
What is the current market size for the Artificial Heartlung Machine Market Report?
The market size in 2023 is $5.70 Billion, as stated in the report data. This figure represents the baseline for the forecast period from 2023 to 2033.
How big will the market be in 2033?
The reported market value for 2033 is $11.65 Billion, reflecting growth over the 2023 baseline across the 2023 to 2033 forecast period.
What is CAGR for the forecast period?
The forecasted compound annual growth rate for 2023 to 2033 is 7.2%, as provided in the input dataset for this market.
Is there a single fastest Growing region in the Artificial Heartlung Machine Market Report market?
No single fastest-growing region is stated for the Artificial Heartlung Machine Market Report market because the top regional implied CAGR values are within 0.15 percentage points of each other, making the ranking too close to call reliably.
Which companies are highlighted as key players?
Top companies listed include Medtronic, Abbott Laboratories, Terumo Corporation, Getinge AB, and Sorin Group, indicating established manufacturers in the field.
What are primary product segments covered?
Product segments include Invasive Devices, Non-Invasive Devices and Consumables, reflecting device categories and ongoing demand for associated supplies.
Who are the main end users for these machines?
End users specified are Hospitals, Ambulatory Surgery Centers, Urgent Care Centers and Research Institutes, representing primary purchasers and clinical operators.
How is regional growth characterized in the report?
Regional figures show expansion across North America, Europe, Asia Pacific, Latin America and Middle East & Africa from 2023 to 2033, with no single regional market region specified.
What applications are included in the segmentation?
Applications listed include Cardiac Surgery, Respiratory Failure, Heart Transplantation, Lung Transplantation and Pediatric Surgery, covering core clinical uses.
What research methods supported the report findings?
Methodology includes primary interviews with industry experts, secondary research from company reports and publications, and data triangulation with internal validation.